#The Juvenile Diabetes Research Foundation

[camillasgirl]

Queen Camilla’s Patronages

The Juvenile Diabetes Research Foundation (JDRF) (President from 12.06.2012)

JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our strength lies in our exclusive focus and singular influence on the worldwide effort to end T1D. Type 1 diabetes is an autoimmune disease that strikes both children and adults suddenly. It has nothing to do with diet or lifestyle. There is nothing you can do to prevent it. And, at present, there is no cure in T1D, your pancreas stops producing insulin—a hormone the body needs to get energy from food. This means a process your body does naturally and automatically becomes something that now requires your daily attention and manual intervention. If you have T1D, you must constantly monitor your blood-sugar level, inject or infuse insulin through a pump, and carefully balance these insulin doses with your eating and activity throughout the day and night.However, insulin is not a cure for diabetes. Even with the most vigilant disease management, a significant portion of your day will be spent with either high or low blood-sugar levels. These fluctuations place people with T1D at risk for potentially life-threatening hypoglycemic and hyperglycemic episodes as well as devastating long-term complications such as kidney failure, heart attack, stroke, blindness and amputation.

[lizbethart-blog]

The Love of a Parent

Dressed as Spiderman for a Halloween party his sophomore year. My son Daniel, was a huge Marvel movie fan. Primarily, Dan’s high school wardrobe consisted of loose-fitting tees and cargo pants, so a close-fitting costume was telling. He was looking quite slender. By early November he had lost 20 lbs. with no clear explanation as to why. I feared my initial gut reaction. Worried and nervous we…

[denim-wrapped-nightmares-podcast]

Over drinks, Berly and LA chat with actor, writer, and producer, Austin Basis, about his experience on the set of Supernatural and the 2010 web series spinoff, Ghostfacers.  Austin is also a celebrity ambassador for the Juvenile Diabetes Research Foundation (JDRF) and currently fundraising for their annual One Walk.  Find more information at https://shorturl.at/bfxAJ.  Thank you to Austin for this discussion.  Now, let's get tipsy!  CW/TW for violent and lewd commentary; listeners beware! 🔞

[newsfromtherooftop]

Couple set to scale Everest in aid of diabetes research

Couple set to scale Everest in aid of diabetes research | Graeme and Leanne Carling hope to raise funds for diabetes charity JDRF #DiabetesResearch

Graeme and Leanne Carling will take on an Everest trek to raise funds for Juvenile Diabetes Research Foundation (JDRF). This month, Graeme and Leanne will travel from their home in Dubai, to Kathmandu in Nepal, taking a short flight to Lukla Airport, dubbed the most dangerous airport in the World, before commencing an 11-day hike to Base Camp Everest at an altitude of 17,594ft. The couple will…

[lboogie1906]

Steven Anthony Davis (born June 8, 1958 - July 10, 2022) was a prominent business leader, a former chairman, and CEO of Bob Evans Farms Inc.

He was born in Milwaukee to Dolores and Henry Joseph Davis. He graduated from the University of Wisconsin- Milwaukee with a BA and earned an MBA from the University of Chicago. He worked at Kraft Foods, rising from brand assistant to senior vice president at the Pizza Hut chain and president of the Long John Silver’s A & W All American Foods. He started the first A&W brand restaurant and introduced the WingStreet concept to Pizza Hut.

He was named chief executive officer of Bob Evans Farms Inc. He was the second non-Evans family member to run the company, which was closely associated with its founder. He was appointed chairman of the Board. He became one of eight African American CEOs of publicly traded companies. Davis was instrumental in the growth of Bob Evans Farms Inc., updating their restaurants and promoting the Mimi’s Cafe chain. However, the sit-down restaurant formats faced challenges from faster service competitors. He resigned in 2014 under pressure from activist investors impatient with his plans.

He appeared in the 75 Most Powerful Black Men in American Business list created by Black Enterprise Magazine. He was recognized as one of the National Association of Corporate Directors Top 100.

He served on the boards of directors of American Eagle Outfitters, PPG, the Juvenile Diabetes Research Foundation, Albertsons, Marathon Petroleum, Legacy Acquisition, CenturyLink, Walgreens Boots Alliance, and Sonic.

He drew inspiration from his parents, who encouraged him and his four siblings to pursue their dreams. Davis recalled, “Their message was that the sky is the limit. They never said that because you are an African American, you can go only this far or do only this or that.” Being a symbol of diversity wasn’t always easy. He recalled finding a noose dangling from a tree branch over the CEO parking spot at Bob Evans headquarters. “I never told my board”, he said. “I just buried it.” #africanhistory365 #africanexcellence

[tritonmarketresearchamey]

Insulin Patch Pump Market: Tech Progress

Insulin therapy is an important aspect of diabetes management and treatment. Today, a number of insulin delivery systems, in the form of pens, syringes, jet injectors, pumps, etc., are used by patients to regulate blood sugar levels. Nowadays, they are increasingly opting for patch pumps or tubeless pumps, which are compact digital devices that deliver insulin doses at regular intervals. The global insulin patch pump market is expected to progress with a CAGR of 10.54% in the forecast period from 2023 to 2030.

The market’s growth can be attributed to the rising popularity of these skin-adhesive devices, surging diabetes prevalence, demand for minimally invasive systems, and increased efforts in R&D. Patch pumps are also more accurate, efficient, affordable, and easier to use than conventional insulin delivery pumps. These products are available in disposable as well as reusable formats, and can function optimally with minimum monitoring. Also, their discrete nature is one of the key factors that has increased their adoption among younger patients.

What’s Influencing Market Growth?

The global burden of diabetes mellitus has burgeoned in recent years, owing to changing lifestyles, rising obesity rates, increasing geriatric population, and unhealthy eating habits. As of 2021, more than 537 million adults worldwide were reported to have diabetes, according to the International Diabetes Federation (IDF) . And with over 74.2 million patients, India accounts for 1 in 7 of all adults affected by the condition.

Moreover, with $165.3 billion in 2021, China accounted for one of the highest diabetes-related healthcare expenditures. The rising diabetes-related healthcare expenditure has consequently increased patient demand for self-management options for diabetes in the region. This is expected to aid the Asia-Pacific insulin patch pump market’s development, with a 10.94% CAGR over the forecast period.

Insulated by Insulin – Investments Boost Product Development

In view of increased spending by consumers, the market faces a higher demand for innovative insulin delivery patch pumps. For instance, JewelPUMP by Debiotech SA is a highly miniaturized insulin delivery patch pump with temperature sensors dedicated for use by both type 1 and type 2 diabetes patients.

While type 1 diabetics comprise a small portion of the total diabetes patient pool, compared to their type 2 counterparts, they are more dependent on insulin therapy. Their pancreas produce little to no insulin, which makes regular insulin intake vital for their survival. In this case, patch pumps are handy as they eliminate the need to carry an insulin infusion set.

Type 1 diabetes is expected to grow with the fastest CAGR of 11.08% in the disease indication segment during 2023-2030. In 2017, the government-backed Canadian Institutes of Health Research (CIHR) and the Juvenile Diabetes Research Foundation (JDRF) Canada announced the CIHR-JDRF Partnership to Defeat Diabetes, with an investment of $30 million in advanced research for type 1 diabetes. This partnership was further renewed, with an additional investment of $15 million in 2021.

Increased investments, coupled with the growing patient demand for accessing health data in a user-friendly format, have led to the development of smart solutions for diabetes care. For instance, in March 2022, Terumo Corporation partnered with SaaS-based app developer Glooko. This has improved the quality of remote patient monitoring, as the users of Terumo’s Medisafe With insulin patch pump can transfer their data on Glooko’s analytics portal, allowing healthcare professionals to view their patients’ latest health records.

AI & ML Technologies Pushing the Frontiers in Diabetes Care

The rising usage of fitness tracking apps, smart wearables, and connected devices by patients to gain real-time insights have paved the way for advanced and technologically-integrated healthcare. For instance, machine learning uses physiological or activity sensors embedded into smart devices or wearables to deliver personalized therapy, which helps lower hyperglycemia and minimize the overall burden.

In addition, the MiniMed 780G by Medtronic Plc is an advanced patch pump that uses artificial intelligence (AI) to automate insulin delivery. It is incorporated with SmartGuard automation for self-adjusting basal delivery with auto-correction dosing and administering bolus insulin. Particularly, the real-time data offered by such technologies has enabled effective remote monitoring of older or specially-abled patients. Improved patient outcomes and experience are thus expected to drive the global AI in healthcare market at a CAGR of 40.48% from 2019 to 2027.

In a Nutshell

Over the years, diabetes management solution providers have worked to keep up with the evolving needs of diabetic patients. With users’ increasing knowledge and understanding of their condition, companies have responded by upgrading their insulin delivery devices, leveraging the power of technology. For instance, integrating insulin patch pumps with continuous glucose monitoring systems has optimized pump use and improved glycemic response. Such innovations by manufacturers are expected to propel the insulin patch pump market on a growth path.

 

FAQs:

Q 1) Which are the key segments considered in the market report?

Product Type, Disease Indication, Delivery Mode, and Distribution Channel.

Q 2) Which country is expected to register the fastest growth rate in the global insulin patch pump market?

Australia is expected to exhibit the fastest growth globally, with a CAGR of 12.28% over the forecast period.

[miraridoctor]

The Juvenile Diabetes Research Foundation (JDRF) is the leading global organization funding research to cure, treat, and prevent type 1 diabetes (T1D). As rates of T1D diagnosis continue rising worldwide, JDRF's mission to improve lives and find solu... #Mirari #MirariDoctor #MirariColdPlasma #ColdPlasma

[namalam]

T-shirt design in support of Team Porter

JDRF One Walk, Lincoln 2023

JDRF, formally known as The Juvenile Diabetes Research Foundation is the leader in research leading to a cure for type 1 diabetes in the world. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Since its founding in 1970 by parents of children with type 1 diabetes, JDRF has awarded more than $2.1 billion to diabetes research.

[tritonmarketresearch]

Insulin Patch Pump Market: Tech Progress

Insulin therapy is an important aspect of diabetes management and treatment. Today, a number of insulin delivery systems, in the form of pens, syringes, jet injectors, pumps, etc., are used by patients to regulate blood sugar levels. Nowadays, they are increasingly opting for patch pumps or tubeless pumps, which are compact digital devices that deliver insulin doses at regular intervals. The global insulin patch pump market is expected to progress with a CAGR of 10.54% in the forecast period from 2023 to 2030.

The market’s growth can be attributed to the rising popularity of these skin-adhesive devices, surging diabetes prevalence, demand for minimally invasive systems, and increased efforts in R&D. Patch pumps are also more accurate, efficient, affordable, and easier to use than conventional insulin delivery pumps. These products are available in disposable as well as reusable formats, and can function optimally with minimum monitoring. Also, their discrete nature is one of the key factors that has increased their adoption among younger patients.

What’s Influencing Market Growth?

The global burden of diabetes mellitus has burgeoned in recent years, owing to changing lifestyles, rising obesity rates, increasing geriatric population, and unhealthy eating habits. As of 2021, more than 537 million adults worldwide were reported to have diabetes, according to the International Diabetes Federation (IDF). And with over 74.2 million patients, India accounts for 1 in 7 of all adults affected by the condition.

Moreover, with $165.3 billion in 2021, China accounted for one of the highest diabetes-related healthcare expenditures. The rising diabetes-related healthcare expenditure has consequently increased patient demand for self-management options for diabetes in the region. This is expected to aid the Asia-Pacific insulin patch pump market’s development, with a 10.94% CAGR over the forecast period.

Insulated by Insulin – Investments Boost Product Development

In view of increased spending by consumers, the market faces a higher demand for innovative insulin delivery patch pumps. For instance, JewelPUMP by Debiotech SA is a highly miniaturized insulin delivery patch pump with temperature sensors dedicated for use by both type 1 and type 2 diabetes patients.

While type 1 diabetics comprise a small portion of the total diabetes patient pool, compared to their type 2 counterparts, they are more dependent on insulin therapy. Their pancreas produce little to no insulin, which makes regular insulin intake vital for their survival. In this case, patch pumps are handy as they eliminate the need to carry an insulin infusion set.

Type 1 diabetes is expected to grow with the fastest CAGR of 11.08% in the disease indication segment during 2023-2030. In 2017, the government-backed Canadian Institutes of Health Research (CIHR) and the Juvenile Diabetes Research Foundation (JDRF) Canada announced the CIHR-JDRF Partnership to Defeat Diabetes, with an investment of $30 million in advanced research for type 1 diabetes. This partnership was further renewed, with an additional investment of $15 million in 2021.

Increased investments, coupled with the growing patient demand for accessing health data in a user-friendly format, have led to the development of smart solutions for diabetes care. For instance, in March 2022, Terumo Corporation partnered with SaaS-based app developer Glooko. This has improved the quality of remote patient monitoring, as the users of Terumo’s Medisafe With insulin patch pump can transfer their data on Glooko’s analytics portal, allowing healthcare professionals to view their patients’ latest health records.

AI & ML Technologies Pushing the Frontiers in Diabetes Care

The rising usage of fitness tracking apps, smart wearables, and connected devices by patients to gain real-time insights have paved the way for advanced and technologically-integrated healthcare. For instance, machine learning uses physiological or activity sensors embedded into smart devices or wearables to deliver personalized therapy, which helps lower hyperglycemia and minimize the overall burden.

In addition, the MiniMed 780G by Medtronic Plc is an advanced patch pump that uses artificial intelligence (AI) to automate insulin delivery. It is incorporated with SmartGuard automation for self-adjusting basal delivery with auto-correction dosing and administering bolus insulin. Particularly, the real-time data offered by such technologies has enabled effective remote monitoring of older or specially-abled patients. Improved patient outcomes and experience are thus expected to drive the global AI in healthcare market at a CAGR of 40.48% from 2019 to 2027.

In a Nutshell

Over the years, diabetes management solution providers have worked to keep up with the evolving needs of diabetic patients. With users’ increasing knowledge and understanding of their condition, companies have responded by upgrading their insulin delivery devices, leveraging the power of technology. For instance, integrating insulin patch pumps with continuous glucose monitoring systems has optimized pump use and improved glycemic response. Such innovations by manufacturers are expected to propel the insulin patch pump market on a growth path.

[atlanticcanada]

Woman with Type 1 diabetes urges N.S. government to increase financial assistance

A 25-year-old woman with Type 1 diabetes is calling on the provincial government to increase financial assistance rates.

Emma Perry was diagnosed with Type 1 diabetes in May 2022.

“I take probably anywhere from five to seven injections a day,” said Perry, who added that insulin injections are partially covered through Nova Scotia Pharmacare with a co-pay.

However, she has other mounting health concerns that are prohibitively expensive.

“That is the limited accessibility to diabetes devices within Nova Scotia,” said Perry, who requires costly equipment to manage her Type 1 diabetes. “Insulin pumps and continuous glucose monitors and flash glucose monitors.”

In Nova Scotia, Perry said there are age limits and income range requirements on all of these items, which means she spends roughly $700 each month without reimbursement.

“I am, for the most part, left my own devices,” said Perry.

Sarah Linklater with the Juvenile Diabetes Research Foundation said Nova Scotia is lagging far behind other Canadian provinces when it comes to providing potentially life-saving coverage.

“Manitoba recently lifted age caps, not just on glucose monitoring devices but on insulin pumps,” said Linklater. “P.E.I. last year announced coverage for continuing glucose monitors and New Brunswick also listed age caps on insulin pump coverage.”

The Nova Scotia Department of Health and Wellness told CTV Atlantic in an email, “We are currently reviewing whether continuous and flash glucose monitoring systems should be added as a publicly insured benefit.”

For now, Perry is faced with a terrifying reality.

“I need to figure out where the money is coming from to provide myself with things I need to stay alive.”

Perry is urging the Nova Scotia government to provide more financial assistance while she continues to live with Type 1 diabetes.

from CTV News - Atlantic https://ift.tt/Xd4unw1

[mr-divabetic]

Prince Be, the frontman for the psychedelic pop-rap group P.M. Dawn, which in the early 1990s died of renal failure resulting from complications of diabetes at age 46.

[1-800-iluvhockey]

ig edit/blurb, whichever is best for you! jack hughes dating reader who has type 1 diabetes, and maybe him raising awareness for it?

this is so cool! I tried my best on this one, because I’m not super familiar with everything! sorry that it’s shorter!

(all photos are not mine and the storyline is fiction!)

——————————

yourusername

liked by @jackhughes86, @elblue06, @njdevils & others

yourusername - happy type one awareness month from banksy & I!! 🐾

tagged @/ jackhughes86

view top comments

jackhughes86 - love you and our little family so much💙

lhughes_06 - best dog mom 😌

njdevils - HAPPY TYPE ONE AWARENESS MONTH TO ALL!! 💙🥰

dawsonmercer - 💉❤️

quinnhughes_- banksy is such a natural in front of the camera! 🐶

elblue06 - love you and banksy so much.🤍🤍

——————————

jackhughes86

liked by @yourusername, @njdevils, @nicohischier13 & others

jackhughes86 - SO excited to announce that with the help of @njdevils, our next home game against the Columbus Blue jackets will be a pretty special night!! My girlfriend Y/n, is type one diabetic, and through her courage and experiences with it; we are having a type one awareness night at the rock!! 25% of all sales (big and small) will be donated to the JDRF!

JDRF, formally known as The Juvenile Diabetes Research Foundation is the leader in research leading to a cure for type 1 diabetes in the world. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide! SO proud to be a partner on making this night happen! Thank you to the NJ Devils organization & we will see you at The Rock, Devs fans!! 👹

tagged @/ njdevils & yourusername

view top comments

njdevils - Thank you for helping us with this, Jack!

yourusername - THIS IS AMAZING!!😯

dawsonmercer - FOR THE KIDS💙

nicohischier13 - 💪🏼💪🏼

quinnhughes_ - amazing work bro!

lhughes_06 - celebrating & supporting type 1 rockstars everywhere 😄

jackhughes86 - gonna be a good night to be a devil fan 😆

——————————

njdevils

liked by @yourusername, @jackhughes86, @jdrf & others

njdevils - Jack surprising our buddy, Charlie before the game tonight against Columbus! Signed jersey & a stick?! Kid is living the dream! #devilsfightdiabetes

tagged @/ jackhughes86

view top comments

nhl - Charlie is a warrior!! Congrats bud!

yourusername - this is a huge step! so proud of my boy @jackhughes86 for doing this for our diabetic community!

jackhughes86 - Charlie is a real speedy skater! So glad to have met him today before our 5-3 W!!

warriorcharlie’smom - It was a honor to do this with the @njdevils !! Charlie loves his new jersey and stick!

njdevils - We love you, Charlie!❤️❤️

jdrf - @njdevils we have to do this again next year!! what a success!

——————————

abbster’s taglist: @hockeyboysarehot @hockey-lover86 @hockey-lover-22 @owenpwr @pulpfixion @studsccsnackavoybambi @bellaguarneri @pierrelucduboiis @oskarlidblom @boeswhore @jamiedryzdale @the-stars-shine-above-us @juliasahoshughes @dylandukerr @dracoswhore007 @calermakar08 @lwstuff @bbrisson19

[margosbloggo]

Margo Hood

Common Application Essay

Fall 2018

“My Dead Pancreas”

March 16, 2015, started off as a normal Monday. I attended school, then my mom picked me up for my yearly well check. ​I didn't think much of it. I was healthy, hardly ever got sick, and felt fine. It was the normal routine: the nurses checked my height, weight, and collected a urine sample from me. My doctor had just started checking my vital signs when a nurse came in stating that she found sugar in my urine. The nurse then checked my blood glucose and the readings were alarmingly high. My doctor exited the room and called Cincinnati Children’s Hospital. He came back and said that the Emergency Room was expecting us. After hours of medical tests and waiting in the Emergency Room, the doctor determined that I had developed Type One Diabetes (T1D).

Receiving the news that your pancreas has died is just as devastating as losing a best friend you never knew you had; you never know how much it means to you until it’s gone. Living with a dead pancreas is not fun. It requires lots of finger pricks, injections, math, weird suntan lines caused by medical devices, and educating those around you of the disease. There is no cure for T1D. I’m stuck with this dead pancreas forever.

When I was first diagnosed, I felt powerless. I didn’t choose or ask to have a dead pancreas, God handed it to me on a silver platter and said, “Enjoy your new life.” It felt like I had returned from the dead. My classmates looked at me as if I were a completely different person. They didn’t understand how one small mistake in an insulin dosage could lead to my death. They just thought I was that crazy girl who talked too much about her disability.

Regardless of what others thought of me, I was determined to retake control of my life. I had to relearn how to love and accept myself. I embraced the tiny spots on my fingertips from finger pricks. I learned to love the scars that my continual glucose monitor sensors and insulin pump sites left behind. I forced myself to use my voice to advocate for a cure and raise awareness about Type One Diabetes.

I didn’t truly learn how to love my diabetes until I became a Juvenile Diabetes Research Foundation (JDRF) Youth Ambassador. Meeting people who were not only around my age but also were fighting the same battle as I was motivated me. I wanted to get involved in the diabetes community more. It made me realize that diabetes is both the ugliest and most beautiful gift that I’ve ever received. Without it, I would not have met some of the amazing and brave people I call my friends. I would not have been able to participate in or know of amazing fundraisers such as JDRF’s annual Cincinnatian Of The Year Gala or American Diabetes Association’s Tour De Cure. I would not have found my voice if it weren't for T1D.

I want to be a nurse (BSN) and Certified Diabetes Educator (CDE) so I can teach newly diagnosed diabetics about their disorder and teach them that diabetes isn’t a burden. I want to teach them that diabetes does not define them; they are stronger than their disorder. But most importantly, I want to educate people around me about diabetes. I want to end the stigma that surrounds this often misunderstood disease.

[photographs taken by Mark Hood (2015 graduation left, 2019 graduation right)]

[dominustempori]

Cursed Chicago Cubs Baseball Destroyed

CHICAGO - FEBURARY 26: Actor/Director Harold Ramis emcees an auction to benefit the Juvenile Diabetes Research Foundation before the ceremony to destroy the cursed Chicago Cubs baseball on February 26, 2004 at Harry Caray's Restaurant in Chicago, Illinois. The alleged curse comes from a play during the NLCS where Luis Castillo of the Marlins hit a foul ball that Cubs fan Steve Bartman touched.

[type1diabetesinfandom]

I was hoping to have this up by November 1st for diabetes awareness month, but as usual, I’m late. Anyway, here’s the link to my AO3 collection of fics where characters have type 1 diabetes.

Anything in the collection’s works feature the main character being diabetic or the diabetes being a primary focus of the story.

The bookmarks are less focused and range from diabetic characters to non-diabetic hypoglycemia to fandoms where there’s a canonical diabetic character but not a focus on it in the individual fic. The bookmarks are all tagged as clearly as I could make them. I listed the specific tags you can filter by in the collection’s FAQ.

If you find a fanfic or other kind of fan work that you would like to see added to the collection, you can 1) add it to the collection’s bookmarks (please add the appropriate tags), 2) invite it to the collection and wait for it to be approved (the collection is open but moderated), or 3) send me the link and l’ll add it myself.

I hope people find this useful :)

*If you’re not diabetic and you’re wondering what National Diabetes Awareness Month is about, I encourage you to look up the Juvenile Diabetes Research Foundation (JDRF) or Beyond Type 1 for more details.

[shipskicksandgiggles]

Diabetic Peter headcannons por favor

oh hell yes

so I’ve kinda done this before here with additional info here but since then I have so many more ideas for this

first of all, he was diagnosed as a small child long before he was Spider-Man. like at 4 years old

so he was pretty used to activity and how to handle his blood sugars on patrol

however because of his new metabolism he had no idea how to handle insulin. the typical fast acting insulin was too fast and he was using too much of it. May’s insurance covered it, but there was always the possibility that it stopped. 

Tony and Bruce worked around the clock with a lot of other scientists to come up with a substitute that could be used at a normal rate, but wasn’t long acting insulin. medium acting insulin was born, and they may start to work on a cure soon

he wears an Omnipod bcuz they have no tubing that could get caught on patrol

he has a Continuous Glucose Monitor or CGM like a Dexcom that connects to his suit. Tony and May both get notifications in case he goes low on patrol

speaking of lows, he has glucose tabs, juice boxes, and the nasty glucose gel for if he can’t chew stored in specialized pockets of his suit. 

his suit also has a protocol for glucagon if he passes out from a low

he always did the walks/runs/rides for cure, but after he becomes a hero he shows up in costume. the newly diagnosed kids love it

oh! and for out of costume

he used to hide it

he stopped caring at some point and now wears his illness with pride

Flash made fun of him once because “my grandma has diabetes. You have a grandma disease, Penis?”

also he can look at a food and tell you exactly how many carbs are in it. it’s not a spider thing. he’s been doing this for far too long and “shut up Ned it’s a habit. That apple is 20 carbs hand me my bag”

his diabetes bag is half Iron Man themed and half Star Trek themed. Ned switched it to Captain America/Star Wars for April Fools Day one year. Peter wouldn’t talk to him for a week

also, please consider checking out the Juvenile Diabetes Research Foundation (JDRF)  website for resources and information on how to help or get involved to help us find a cure in real life. it would mean a lot to me personally. you can find them at https://www.jdrf.org/

I think that’s all I have for now? a lot of these are going into a fic I plan to write soon actually

send in more prompts/ideas for headcanon lists at any time!